[(1R)-1-[[(2R,3R)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2R)-2-formamido-4-methyl-pentanoate (111466-61-6)

Identification
Name:	[(1R)-1-[[(2R,3R)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2R)-2-formamido-4-methyl-pentanoate
Synonyms:	LogP
CAS:	111466-61-6
Molecular Formula:	C₂₉H₅₃NO₅
Molecular Weight:	495.7348
InChI:	InChI=1/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m1/s1
Molecular Structure:
Properties
Flash Point:	326.27°C
Boiling Point:	615.876°C at 760 mmHg
Density:	0.977g/cm³
Refractive index:	1.47
Flash Point:	326.27°C
Safety Data

Other Product

[(1S)-1-[[(2R,3R)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2R)-2-formamido-4-methyl-pentanoate
[(1R)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2R)-2-formamido-4-methyl-pentanoate
[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-(benzyloxycarbonylamino)-4-methyl-pentanoate
(2R)-4-methyl-2-(methylammonio)pentanoate
(2R,3R,4R)-2-(6-amino-9H-purin-9-yl)-4-(hydroxymethyl)oxetan-3-ol
2-Anthracenecarboxylicacid, 1,2,3,4-tetrahydro-1,2,8-trihydroxy-3-methyl-1-(3-methylbutyl)-4-oxo-,(1R,2R,3R)-
(S)-Methyl 2-forMaMido-3-(4-iodophenyl)propanoate
2-Azetidinecarboxaldehyde,3-methoxy-1-methyl-4-oxo-, (2R,3R)-
Cyclopropanecarboxylicacid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-,3-[(3-ethenyloxiranyl)methyl]-2-methyl-4-oxo-2-cyclopenten-1-yl ester, [2R-[2a[S*(1R*,3R*)],3a]]- (9CI)
Cyclopropanecarboxylicacid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-,3-(2,3-dihydroxy-4-pentenyl)-2-methyl-4-oxo-2-cyclopenten-1-yl ester, [1R-[1a[S*(2R*,3R*)],3b]]- (9CI)
Butanoic acid,2-methyl-,(1S,2R)-1-[(1R)-1-[(2R,3R)-6-ethyl-3,4-dihydro-3,5-dimethyl-4-oxo-2H-pyran-2-yl]ethyl]-2-methyl-3-oxopentylester, (2R)-
S-(2-(((4-Amino-2-methyl-5-pyrimidinyl)methyl)formamido)-1-(2-(benzoyloxy)ethyl)prop-1-enyl) thiobenzoate, mono(dodecyl sulphate)
2-Oxazolidinethione,3-[(2R,3R)-3-hydroxy-1-oxo-2-(2-propenyloxy)hexyl]-4-(phenylmethyl)-,(4S)-
Cyclopentaneheptanoicacid,3-hydroxy-2-[(1E,4R)-4-hydroxy-4-(1-propylcyclobutyl)-1-buten-1-yl]-5-oxo-,methyl ester, (1R,2R,3R)-
5-Heptenamide,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-N-[6-(nitrooxy)hexyl]-, (5Z)-
4-Penten-2-ol, 3-methyl-5-[(1R)-2,2,3-trimethyl-3-cyclopenten-1-yl]-,(2R,3R,4E)-
Bicyclo[4.1.0]heptan-2-ol,3,7-dimethyl-7-(4-methyl-3-penten-1-yl)-, (1R,2R,3R,6S,7R)-rel-
2-Propenoic acid,3-[4-[(2S)-2-[[(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-1-oxo-5-hepten-1-yl]amino]-1-oxopropoxy]-3-methoxyphenyl]-, [4-[(nitrooxy)methyl]phenyl]methyl ester, (2E)-
3-{[(2R,3S)-3-ethenyloxiran-2-yl]methyl}-2-methyl-4-oxocyclopent-2-en-1-yl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate
[(2R,3R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-tetrahydrofuran-2-yl]methyl 4-methylbenzenesulfonate